GeneDx Holdings Corp

자세한 내용은 회사

회사 정보

종목 코드 WGS

회사 이름GeneDx Holdings Corp

상장일Sep 04, 2020

CEOMs. Katherine A. Stueland

직원 수1000

유형Ordinary Share

회계 연도 종료Sep 04

주소333 Ludlow Street

도시STAMFORD

증권 거래소NASDAQ Global Select Consolidated

국가United States of America

우편 번호06902

전화18887291206

웹사이트https://sema4.com/

종목 코드 WGS

상장일Sep 04, 2020

CEOMs. Katherine A. Stueland

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Joshua Ruch

Independent Director

223.99K

+6.12%

Dr. Emily M. Leproust, Ph.D.

Independent Director

33.16K

+63.87%

Mr. Kevin Feeley

Chief Financial Officer

9.12K

+121.37%

Mr. Keith A. Meister

Independent Director

3.58K

-82.23%

Dr. Thomas Fuchs

Director

--

Dr. Bryan Dechairo

Chief Operating Officer

--

Ms. Katherine A. Stueland

Chief Executive Officer, Director

--

Mr. Jason Michael Ryan, CPA

Chairman of the Board

--

Mr. Eli D. Casdin

Independent Director

--

Mr. Richard C. (Rick) Pfenniger, Jr.

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Joshua Ruch

Independent Director

223.99K

+6.12%

Dr. Emily M. Leproust, Ph.D.

Independent Director

33.16K

+63.87%

Mr. Kevin Feeley

Chief Financial Officer

9.12K

+121.37%

Mr. Keith A. Meister

Independent Director

3.58K

-82.23%

Dr. Thomas Fuchs

Director

--

Dr. Bryan Dechairo

Chief Operating Officer

--

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Patients with third party insurance

68.06M

78.13%

Institutional customers

17.60M

20.21%

Other

1.36M

1.56%

Self pay patients

96.00K

0.11%

데이터 없음

사업별

지역별

사업별USD

이름

수익

비율

Patients with third party insurance

68.06M

78.13%

Institutional customers

17.60M

20.21%

Other

1.36M

1.56%

Self pay patients

96.00K

0.11%

주식 보유 통계

마지막 업데이트: Sat, Aug 16

주주

주주 유형

주주

비율

Corvex Management LP

10.65%

Casdin Capital, LLC

10.60%

William Blair Investment Management, LLC

5.68%

Icahn School of Medicine at Mount Sinai

4.78%

OPKO Health Inc

4.77%

기타

63.52%

주주

비율

Corvex Management LP

10.65%

Casdin Capital, LLC

10.60%

William Blair Investment Management, LLC

5.68%

Icahn School of Medicine at Mount Sinai

4.78%

OPKO Health Inc

4.77%

기타

63.52%

주주 유형

주주

비율

Hedge Fund

36.39%

Investment Advisor/Hedge Fund

35.06%

Investment Advisor

30.43%

Corporation

10.71%

Research Firm

6.56%

Individual Investor

1.68%

Pension Fund

0.81%

Venture Capital

0.54%

Bank and Trust

0.48%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

397

34.23M

119.24%

+1.02M

2025Q1

398

32.79M

115.46%

-47.86K

2024Q4

341

29.17M

104.22%

+1.72M

2024Q3

289

26.18M

97.50%

+377.48K

2024Q2

262

24.98M

95.33%

+588.25K

2024Q1

260

22.13M

86.19%

+1.41M

2023Q4

271

20.57M

80.67%

-567.28K

2023Q3

283

21.68M

85.29%

-751.02K

2023Q2

291

21.85M

86.03%

-864.88K

2023Q1

296

21.58M

684.27%

+3.47M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Corvex Management LP

2.91M

10.19%

+434.85K

+17.58%

May 05, 2025

Casdin Capital, LLC

3.53M

12.36%

--

May 05, 2025

William Blair Investment Management, LLC

1.19M

4.17%

+518.99K

+77.46%

Mar 31, 2025

Icahn School of Medicine at Mount Sinai

1.37M

4.81%

-1.35M

-49.50%

Feb 21, 2025

OPKO Health Inc

1.37M

4.8%

-800.83K

-36.88%

Nov 20, 2024

BlackRock Institutional Trust Company, N.A.

1.04M

3.64%

-41.94K

-3.89%

Mar 31, 2025

The Vanguard Group, Inc.

1.03M

3.6%

+23.46K

+2.34%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

503.73K

1.77%

+503.73K

--

Mar 31, 2025

117.210USD

GeneDx Holdings Corp

117.210

개요

회사

금융

분석